版權說明：本文檔由用戶提供并上傳，收益歸屬內容提供方，若內容存在侵權，請進行舉報或認領
文檔簡介
CHRONIC
OBSTRUCTIVE
PULMONARY
DISEASECHRONIC
OBSTRUCTIVE
PULMONARY
AIMSOFTHISSESSIONToUnderstandthedefinition DiscusscausesDiscussdiagnosis DiscussManagement/MedicationDiscussOxygenTherapyandenjoy!AIMSOFTHISSESSION【COPD英文教學講解課件】COPD-(42p)【COPD英文教學講解課件】COPD-(42p)
DEFINITION
COPDischaracterisedbyairflowobstruction.
airflowobstructionisusuallyprogressiveItisnotfullyreversibledoesnotchangemarkedlyoverseveralmonths.Thediseaseispre-dominantlycausedbysmoking.
COPD
isanumbrellatermfor
EmphysemaChronicBronchitisSevereChronicAsthmaNICE(2010)COPDisanumbrellatermfor
CHRONICBRONCHITISContinuousinflammationofthecellsliningthebronchiMucoushypersecretionDestructionofthecilia,impairingmucousclearanceleadingtoincreasedriskofinfectionDiagnosedbytheproductionofsputumandcoughonmostdaysforthreemonthsintwoconsecutiveyearsCHRONICBRONCHITIS
EMPHYSEMA
DestructiveofthealveoliandterminalbronchiolesLossofelasticityofsmallerairwaysLossofpatencyofbronchiolesEMPHYSEMADest
CAUSESOFCOPDSMOKING:
90%ofcases,arecausedbysmoking15%aresusceptible.Lungfunctiondeclineis3timesfasterIfsmokingstops,atoneyearFEV1declineisagerelated(Morgan&Britton2003)ALPHA1ANTITRIPSINDEFICIENCY:GENETICFoundinonly1%ofcases.OCCUPATIONALEXPOSURETORESPIRATORYPOLLUTANTS:Chemicals,dust,atmosphericpollutants,inheritedtendencyCAUSESOFCNearly30,000deathsayear-accountingfor5%ofalldeaths,onedeathevery20mins850,000diagnosed–only33%Probably2millionundiagnosed“MissingMillions”(BLF2009)COPDisthefourthmostcommoncauseofdeathafterheartdisease,lungdiseaseandcerebrovasculardiseaseNearly30,000deathsayear-acCOPDistheonlyleadingcauseofdeaththatisincreasinginprevalencewithatotalcost￡850million/yr-24millionworkingdayslost-
CigarettesmokingisthemajorcauseofCOPD90%MortalityfromCOPDisincreasinginwomenwhilereachingaplateauinmenUnlesscurrenttrendsarereversed,COPDmaybecomethebiggestpublichealthproblem.DeathrateoneofworstinEuropeCOPDistheonlyleadingcause【COPD英文教學講解課件】COPD-(42p)
DIAGNOSISOver35SmokerorexsmokernoclinicalfeaturesofasthmaHaveanyofthesesymptoms?exertionalbreathlessnesschroniccoughregularsputumproductionfrequentwinter“bronchitis”Wheeze(NICE2010)DIACOPDORASTHMA?COPDAsthmaSmoker/exsmokerNearlyallPossiblySymptomsunderageof35RareCommonChronicproductivecoughProgressiveandpersistentVariableBreathlessnessProgressiveandpersistentVariableNighttimewakingwithbreathlessnessand/orwheezeUncommonCommonSignificantdiurnalordaytodayvariationUncommonCommonCOPD
SPIROMETRYSpirometrymeasuresthevolumeofairexpiredfromthelungsduringasinglemaximalforcedexpiration.Thekeymeasurementsare:-ForcedVitalcapacity(FVC)ForcedExpiratoryVolumeinonesecond(FEV1)FVC/FEV1RatioSPIR
CLASSIFICATIONOFCOPDMILD FEV1>80%MODERATE FEV150-80%SEVERE FEV130-50%VERYSEVEREFEV1,30%NICEGUIDELINE(2010))CLASSIFICATIONCOPDproducessymptoms,disabilityimpairedqualityoflife-mayrespondtopharmacologicaltherapiesAirflowobstructionwillnotrespondtothesetherapiessobewareofarelianceonSpirometry.COPDproduces
SYMPTOMSASSOCIATEDWITHANEXACERBATION
DYSPNOEAMorebreathlessthannormalReducedexercisetoleranceSPUTUMPRODUCTIONIncreaseinpurulenceSPUTUMVOLUMEIncreaseinnormalamountCOUGH
SYMPTOMSASSOCIINVESTIGATIONSChestXrayArterialbloodgas–canaidmedicaldiagnosisECGFBC,UreaandElectrolytesTheophyllinelevelsifappropriateSputummicroscopy/cultureifpurulentINVESTIGATIONS
OBSERVATIONS/MONITORINGRESPIRATORYrate/rhythm/workload/equalO2Sats–90-92%Colourskin,lips,nails(clubbing)Patientabletospeakinsentences/wordsornotatallTemp/Pulse/BPConfusionurineoutputPeripheraloedemaDepression/lethargyAssessneedforNIV/IVNotneeded-PEFROBSERVATIONS/MONITORINTREATMENTRegularbronchodilatortherapy(considerIVaminophyllineifpoorresponsetonebs)Continue/startOralantibioticsContinue/startoralPrednisolone(continueinhaledsteroidsalsoastakes7–10daystokickin)Oxygentherapyas
prescribed
(dependantonbloodgasresultandSatsO2)NoninvasiveVentilationTREATMENT【COPD英文教學講解課件】COPD-(42p)
NURSINGMANAGEMENTLiasewithmultidisciplinaryteammemberstoprovidespecialisedcare.Diseaseprocess/progressionInhalers/medicationSmokingcessationNutritionNURSINGMANAGEMENTPulmonaryrehab/CommunityMatron/Breathlessnessclinic/SupportgroupVaccinationsPhysiotherapist-Breathingexercises,expectoration,copingmechanisms,energyconservationBenefitsFurtherexacerbations-ExacerbationselfmanagementplanandstandbyantibioticsandsteroidsPulmonaryrehab/CommunityMatPREDISCHARGEMANAGEMENTSpirometryBloodgasFullknowledgeoftreatment–correctinhalertechniqueSelfmanagementplanreantibioticsandsteroidsathomeFUappt-withRespiratoryNursesifO2indicatedRefertoPulmonaryrehabChecksmokingstatusPREDISCHARGEMANAGEMENT
ENDofLIFE?PalliativecareregisterAdvanceddirectives/PPC/AssessmentofconcernsHospice/dayhospitalENDo【COPD英文教學講解課件】COPD-(42p)
COMPLICATIONSOFCOPD.
RESPIRATORYFAILURECORPULMONALE
POLYCYTHAEMIAPULMONARYEMBOLIDEPRESSION/ANXIETYCOMPLICATIONSOFCOPD.R
RESPIRATORYFAILURETYPE1RespiratoryFailurePaO2below8Kpa(60.80mmHg)withnormal/lowPaCO2TYPE2RespiratoryFailure:PaO2,below8kpa(60.8mmHg)andincreasedPaCO2above6.5kPa(49.4mmHg)RESPIRATORYFAILURE
AIMSOFTHERAPYPreventfurtherdiseaseprogressionRelievesymptomsImproveexercisecapacityMaintainbestqualityoflifePreventexacerbationsAIMSOFTHERAPYPreven
MEDICATIONS
BronchodilatorsshouldbetheinitialtreatmentAssesseffectivenessbyimprovementinsymptomsADLexercisecapacityrapidityofreliefofsymptomsNote-FEV1willnotreflectanysignificantimprovementMEDICATIONS
Bro
MEDICATIONSIfsymptomspersistaddLongactinganticholinergic.Long-actingB2agonistMEDICATIONSIfsympt
MEDICATIONSInhaledsteroids-forallCOPDpts?MethylxanthinesAntidepressantsMucolyticsMEDICATIONSInTREATMENTFACTORSAFFECTINGCONCORDANCEOFINHALEDMEDICATIONSDrugregime -Toocomplex -Frequencyofdosing -Unsuitableinhalerierheumatic,elderlyLackofnoticeableimmediatebenefiteginhaledsteroidsandlongactingbronchodilatorsMultipleprescriptioncharges
TREATMENTFACTORSAFFECTINGC
NONTREATMENTFACTORSLackofunderstandingoftreatmentinclackofclearinstructionsFearofsideeffectsDislike/distrustofhealthserviceReluctancetoacceptdiagnosisPreferenceforalternativetherapiesLackofsocialsupport/familycircumstancesLanguage,readingoreyesightdifficultiesNONTREA【COPD英文教學講解課件】COPD-(42p)LONGTERMOXYGENTHERAPYLTOTisconsideredinpatientswith
PaO2of7.3kPawhenstableorPaO2of7.3–8kPawithoneofthefollowing:secondarypolycytheamianocturnalhypoxaemia,peripheraloedemaorpulmonaryhypertensionSevereairflowobstruction–FEV1<30%LONGTERMOXYGENTHERAPerformedinsecondarycareInitial-6weekspostexacerbation,clinicallystableSecondassessment–3-4weekslaterwithtrialofoxygenLTOTshouldbeusedforatleast15hrs/dayviaaconcentratorinstalledbycompanyASSESSMENTPerformedinsecondarycare
SHORTBURSTOXYGENNoevidencetosupportitsuseinCOPD.Usedmoreforsymptomreliefinfibrosis/palliativecareforshortburstsonlybycylinderCanbeprescribedbyGPSHORTBURST
AMBULATORYOXYGENEvidenceofdesaturationonexercise6minwalktestmonitoredbysaturations.Lightweightcylinders+/-conserverdeviceAMBULATORYOXYCHRONIC
OBSTRUCTIVE
PULMONARY
DISEASE
EndCHRONIC
OBSTRUCTIVE
PULMONARY
RESPIRATORYNURSESALISONCALVERTRLI/WGHEXT3608/5611MOBILE07917240710SARAHJEWELLFGHPAGERVIASWITCHEXT1502HELENBOOTHRLIBLEEP767EXT3608RESPIRATORYNURSESCHRONIC
OBSTRUCTIVE
PULMONARY
DISEASECHRONIC
OBSTRUCTIVE
PULMONARY
AIMSOFTHISSESSIONToUnderstandthedefinition DiscusscausesDiscussdiagnosis DiscussManagement/MedicationDiscussOxygenTherapyandenjoy!AIMSOFTHISSESSION【COPD英文教學講解課件】COPD-(42p)【COPD英文教學講解課件】COPD-(42p)
DEFINITION
COPDischaracterisedbyairflowobstruction.
airflowobstructionisusuallyprogressiveItisnotfullyreversibledoesnotchangemarkedlyoverseveralmonths.Thediseaseispre-dominantlycausedbysmoking.
COPD
isanumbrellatermfor
EmphysemaChronicBronchitisSevereChronicAsthmaNICE(2010)COPDisanumbrellatermfor
CHRONICBRONCHITISContinuousinflammationofthecellsliningthebronchiMucoushypersecretionDestructionofthecilia,impairingmucousclearanceleadingtoincreasedriskofinfectionDiagnosedbytheproductionofsputumandcoughonmostdaysforthreemonthsintwoconsecutiveyearsCHRONICBRONCHITIS
EMPHYSEMA
DestructiveofthealveoliandterminalbronchiolesLossofelasticityofsmallerairwaysLossofpatencyofbronchiolesEMPHYSEMADest
CAUSESOFCOPDSMOKING:
90%ofcases,arecausedbysmoking15%aresusceptible.Lungfunctiondeclineis3timesfasterIfsmokingstops,atoneyearFEV1declineisagerelated(Morgan&Britton2003)ALPHA1ANTITRIPSINDEFICIENCY:GENETICFoundinonly1%ofcases.OCCUPATIONALEXPOSURETORESPIRATORYPOLLUTANTS:Chemicals,dust,atmosphericpollutants,inheritedtendencyCAUSESOFCNearly30,000deathsayear-accountingfor5%ofalldeaths,onedeathevery20mins850,000diagnosed–only33%Probably2millionundiagnosed“MissingMillions”(BLF2009)COPDisthefourthmostcommoncauseofdeathafterheartdisease,lungdiseaseandcerebrovasculardiseaseNearly30,000deathsayear-acCOPDistheonlyleadingcauseofdeaththatisincreasinginprevalencewithatotalcost￡850million/yr-24millionworkingdayslost-
CigarettesmokingisthemajorcauseofCOPD90%MortalityfromCOPDisincreasinginwomenwhilereachingaplateauinmenUnlesscurrenttrendsarereversed,COPDmaybecomethebiggestpublichealthproblem.DeathrateoneofworstinEuropeCOPDistheonlyleadingcause【COPD英文教學講解課件】COPD-(42p)
DIAGNOSISOver35SmokerorexsmokernoclinicalfeaturesofasthmaHaveanyofthesesymptoms?exertionalbreathlessnesschroniccoughregularsputumproductionfrequentwinter“bronchitis”Wheeze(NICE2010)DIACOPDORASTHMA?COPDAsthmaSmoker/exsmokerNearlyallPossiblySymptomsunderageof35RareCommonChronicproductivecoughProgressiveandpersistentVariableBreathlessnessProgressiveandpersistentVariableNighttimewakingwithbreathlessnessand/orwheezeUncommonCommonSignificantdiurnalordaytodayvariationUncommonCommonCOPD
SPIROMETRYSpirometrymeasuresthevolumeofairexpiredfromthelungsduringasinglemaximalforcedexpiration.Thekeymeasurementsare:-ForcedVitalcapacity(FVC)ForcedExpiratoryVolumeinonesecond(FEV1)FVC/FEV1RatioSPIR
CLASSIFICATIONOFCOPDMILD FEV1>80%MODERATE FEV150-80%SEVERE FEV130-50%VERYSEVEREFEV1,30%NICEGUIDELINE(2010))CLASSIFICATIONCOPDproducessymptoms,disabilityimpairedqualityoflife-mayrespondtopharmacologicaltherapiesAirflowobstructionwillnotrespondtothesetherapiessobewareofarelianceonSpirometry.COPDproduces
SYMPTOMSASSOCIATEDWITHANEXACERBATION
DYSPNOEAMorebreathlessthannormalReducedexercisetoleranceSPUTUMPRODUCTIONIncreaseinpurulenceSPUTUMVOLUMEIncreaseinnormalamountCOUGH
SYMPTOMSASSOCIINVESTIGATIONSChestXrayArterialbloodgas–canaidmedicaldiagnosisECGFBC,UreaandElectrolytesTheophyllinelevelsifappropriateSputummicroscopy/cultureifpurulentINVESTIGATIONS
OBSERVATIONS/MONITORINGRESPIRATORYrate/rhythm/workload/equalO2Sats–90-92%Colourskin,lips,nails(clubbing)Patientabletospeakinsentences/wordsornotatallTemp/Pulse/BPConfusionurineoutputPeripheraloedemaDepression/lethargyAssessneedforNIV/IVNotneeded-PEFROBSERVATIONS/MONITORINTREATMENTRegularbronchodilatortherapy(considerIVaminophyllineifpoorresponsetonebs)Continue/startOralantibioticsContinue/startoralPrednisolone(continueinhaledsteroidsalsoastakes7–10daystokickin)Oxygentherapyas
prescribed
(dependantonbloodgasresultandSatsO2)NoninvasiveVentilationTREATMENT【COPD英文教學講解課件】COPD-(42p)
NURSINGMANAGEMENTLiasewithmultidisciplinaryteammemberstoprovidespecialisedcare.Diseaseprocess/progressionInhalers/medicationSmokingcessationNutritionNURSINGMANAGEMENTPulmonaryrehab/CommunityMatron/Breathlessnessclinic/SupportgroupVaccinationsPhysiotherapist-Breathingexercises,expectoration,copingmechanisms,energyconservationBenefitsFurtherexacerbations-ExacerbationselfmanagementplanandstandbyantibioticsandsteroidsPulmonaryrehab/CommunityMatPREDISCHARGEMANAGEMENTSpirometryBloodgasFullknowledgeoftreatment–correctinhalertechniqueSelfmanagementplanreantibioticsandsteroidsathomeFUappt-withRespiratoryNursesifO2indicatedRefertoPulmonaryrehabChecksmokingstatusPREDISCHARGEMANAGEMENT
ENDofLIFE?PalliativecareregisterAdvanceddirectives/PPC/AssessmentofconcernsHospice/dayhospitalENDo【COPD英文教學講解課件】COPD-(42p)
COMPLICATIONSOFCOPD.
RESPIRATORYFAILURECORPULMONALE
POLYCYTHAEMIAPULMONARYEMBOLIDEPRESSION/ANXIETYCOMPLICATIONSOFCOPD.R
RESPIRATORYFAILURETYPE1RespiratoryFailurePaO2below8Kpa(60.80mmHg)withnormal/lowPaCO2TYPE2RespiratoryFailure:PaO2,below8kpa(60.8mmHg)andincreasedPaCO2above6.5kPa(49.4mmHg)RESPIRATORYFAILURE
AIMSOFTHERAPYPreventfurtherdiseaseprogressionRelievesymptomsImproveexercisecapacityMaintainbestqualityoflifePreventexacerbationsAIMSOFTHERAPYPreven
MEDICATIONS
BronchodilatorsshouldbetheinitialtreatmentAssesseffectivenessbyimprovementinsymptomsADLexercisecapacityrapidityofreliefofsymptomsNote-FEV1willnotreflectanysignificantimprovementMEDICATIONS
Bro
MEDICATIONSIfsymptomspersistaddLongactinganticholinergic.Long-actingB2agonistMEDICATIONSIfsympt
MEDICATIONSInhaledsteroids-forallCOPDpts?MethylxanthinesAntidepressantsMucolyticsMEDICATIONSInTREATMENTFACTORSAFFECTINGCONCORDANCEOFINHALEDMEDICATIONSDrugregime -Toocomplex -Frequencyofdosing -Unsuitableinhalerierheumatic,elderlyLacko
溫馨提示
- 1. 本站所有資源如無特殊說明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙，網頁內容里面會有圖紙預覽，若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間，僅對用戶上傳內容的表現方式做保護處理，對用戶上傳分享的文檔內容本身不做任何修改或編輯，并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容，請與我們聯系，我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 醫學科普職業規劃
- 行政管理與公共關系的培訓實踐試題及答案
- 基礎與進階工程經濟試題及答案
- 2025年市政工程政策理解試題及答案
- 關鍵知識的2025年中級經濟師試題及答案
- 文化傳媒行業考察與鑒賞題目
- 環保材料采購與綠色生產實踐
- 公共關系學的傳播策略試題及答案
- 工程經濟中的收益評估試題及答案
- 食品科學與工程生產線操作練習題
- GB 4053.1-2009固定式鋼梯及平臺安全要求第1部分：鋼直梯
- 膠水MSDS安全技術說明書
- 四年級數學 《軸對稱》
- 危險化學品技術要求MSDS(氬氣)
- 出租房屋安全檢查記錄
- 消防工程計量和計價課件
- 突發公共衛生事件流行病學-課件
- 2021國家開放大學《公共關系學》網上課程形考任務1-4附參考答案
- 液壓氣動技術課程設計報告
- 體育館專業擴聲設計方案
- 變電站八項新版制度
評論
0/150
提交評論